Tourmaline Bio
Gerhard Hagn, PharmD, is the Head of Commercial & Business Development at Tourmaline Bio. Prior to this role, Gerhard held high-level positions at Gilead Sciences and Pfizer, where Gerhard demonstrated strong leadership in commercial strategy and portfolio management. With a background in pharmacy, Hagn has a track record of achieving results and driving growth in the biotechnology and pharmaceutical industry.
This person is not in any teams
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.